Antiretroviral therapy (ART) has evolved considerably over the past three decades. With many antiretroviral (ARV) drugs, combinations, and classes available, health care providers have multiple choices regarding ARV therapy. While these choices provide health care providers with many options, they also lead to challenges. One of the biggest challenges for clinicians is individualizing the care of HIV-positive patients and understanding when certain ARV therapies and strategies are appropriate, and when they are not. Numerous studies have shown that ARV therapy must be tailored to the individual patient and his or her abilities and diverse needs. A "cookie-cutter" or "one size fits all" approach can lead to poor outcomes, with higher rates of virologic failure and ARV-related toxicities. With the wealth of choices available, the challenge for health care providers remains weighing the relative benefits and risks of each ARV and ARV combination and creating an appropriate ARV regimen that is potent, tolerable, safe, and durable.
This web symposium features Drs. Calvin Cohen and Joseph Eron who describe and discuss current guidelines and recent research findings and explain how to provide optimal care for a wide variety of HIV patients. By participating in this online program, clinicians and other health care providers will gain the tools they need to reduce morbidity and mortality and improve outcomes of HIV patients.
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals actively involved in the treatment and management of patients with HIV-infection. It is tuition-free and there are no prerequisites.
Upon completion of the program, participants should be better able to:
Release Date: August 18, 2014
Expiration Date: August 18, 2015
Estimated time to complete the Web Symposium: 2 hours
Media: Internet
Calvin J. Cohen, MD, MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
Joseph Eron, MD
Professor
University of North Carolina
School of Medicine
Chapel Hill, North Carolina
Wilbert Jordan, MD
Medical Director,
Charles Drew Medical Center
Los Angeles, California
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Dr. Calvin Cohen:
Dr. Joseph Eron:
Dr. Wilbert Jordan:
The following PIM staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content:, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP and Jan Shultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME/CE activity of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planner. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
There are no fees for participating and receiving CME credit for this activity. During the period, August 18, 2014 through August 18, 2015, participants must read the learning objectives and faculty disclosures and study the educational activity.
PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on www.cmeuniveristy.com. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 10181. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Supported by an Educational Grant by Merck & Co.
